
Simplify your compound management with Compound Connect - mailchi.mp/28268b4db887/comp…

A truly integrated drug discovery service: medicinal & computational chemistry, in vitro biosciences, DMPK, compound management and a diverse screening library.

Simplify your compound management with Compound Connect - mailchi.mp/28268b4db887/comp…

GPCR Drug Discovery at BioAscent - mailchi.mp/892b35a67887/prot…

Our customers choose BioAscent to cost-effectively and securely manage their compounds, connect their CRO network, and accelerate their design-make-test cycles. Find out more: bit.ly/3qKVEjR #DrugDiscovery #CompoundManagement

The @ELRIG_UK Protein Sciences in Drug Discovery meeting is underway at Hinxton Hall Conference Centre, Cambridgeshire. If you would like to arrange a meeting with David, please get in touch: info@bioascent.com. Find out more: bit.ly/3ZacwBL #ProteinScience2024

Senior BioAscent scientists, Duncan McArthur and Angelo Pugliese, named as authors on recent paper: ‘Reversible small molecule pan-Ras inhibitors display tunable affinity for the active and inactive forms of Ras’. Read the paper here: bit.ly/4fwa7Hv #DrugDiscovery

Our computational chemists have years of knowledge and success applying multiple in silico ligand-based and structure-based methodologies at all stages of the drug discovery workflow. Find out more: bit.ly/372bPC7 #CompChem #LigandModelling #ComputationalChemistry

The @ELRIG_UK Protein Sciences in Drug Discovery meeting begins next week. If you would like to arrange a meeting, please get in touch by emailing info@bioascent.com. Find out more about the meeting: bioascent.com/news-events/ev… #ProteinScience2024 #IntegratedDrugDiscovery

BIO-Europe is underway in Stockholm, Sweden. Business Development Director for Europe Michalina Lewicka-Yammine is attending and is available to answer questions about our services. To arrange a meeting, get in touch: info@bioascent.com. Find out more: bioascent.com/news-events/ev…

Find out more about the partnership on our website: bioascent.com/news-events/ne… #TargetedProteinDegradation #IntegratedDrugDiscovery

The collaboration brings together BioAscent’s world-class pre-clinical drug discovery expertise with Dundee’s globally recognised leadership and experience in the field of targeted protein degradation.

This partnership will focus on the development and application of innovative chemistry methods to streamline the synthesis and testing of protein degrader molecules – a revolutionary area of therapeutic discovery.

We're pleased to announce the successful award of a Knowledge Transfer Partnership with the Centre for Targeted Protein Degradation at the School of Life Sciences, at the @dundeeuni.

BioAscent's Business Development Director for Europe Michalina Lewicka-Yammine had the pleasure of attending the @EBDgroup Bio-Europe reception last night ahead of the main event. Find out more: bit.ly/40iTNVN #BIOEurope #Event #Networking #IntegratedDrugDiscovery

Today, we're showing appreciation to our brilliant team with some special spooky-themed goody bags. Each treat is a small token of gratitude for their hard work and commitment. Wishing everyone a happy Halloween. #TeamAppreciation #EmployeeRecognition #IntegratedDrugDiscovery

Our state-of-the-art facility securely stores and manages customer libraries varying in size from tens of compounds, through to hundreds-of-thousands of compounds, in liquid and solid formats. Find out more: bit.ly/3qKVEjR #CompoundManagement #CompoundStorage

Bio-Europe begins next week in Stockholm. Business Development Director for Europe Michalina Lewicka‑Yammine will be attending the event. To arrange a meeting, email info@bioascent.com. Find out more: bit.ly/40iTNVN @EBDgroup #BIOEurope #IntegratedDrugDiscovery